Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen CAMBRIDGE, United Kingdom, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Exonate, an mRNA therapy company focused on retinal diseases, today announced that in collaboration with Janssen Pharmaceuticals, Inc.,...